3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Recruiting
2
Enrolling by invitation
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Prolactinoma
2
Hyperprolactinemia
2
Prolactin Deficiency, Isolated
1
Interventions
Specimen Handling
479
pembrolizumab
454
Magnetic Resonance Spectroscopy
421
Carboplatin
327
Cyclophosphamide
313
Cisplatin
271
Biopsy
270
Radiotherapy
245
Paclitaxel
230
Gemcitabine
228
Bevacizumab
211
Nivolumab
188
fludarabine
185
venetoclax
174
Drug Therapy
170
Dexamethasone
158
Blood Specimen Collection
158
Oxaliplatin
155
Injections
152
Capecitabine
152
Fluorouracil
144
Docetaxel
142
Standard of Care
135
Radiosurgery
135
Rituximab
125
Pemetrexed
118
durvalumab
115
Leucovorin
108
Radiation
107
atezolizumab
105
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Cabergoline
×
1 year
×
Clear all
NCT07463235
2026-03-13
SPARAGMOS
University of Sao Paulo General Hospital
Phase 3
Recruiting
70 enrolled
NCT07045935
2025-09-23
ProBOLIC
University Hospital, Basel, Switzerland
Phase 4
Recruiting
60 enrolled